Raphael Mechoulam Pages 1313 - 1322 ( 10 )
Research leading to the isolation of the plant cannabinoids during the 1960s and to the endogenous cannabinoids, during the 1990s is described. Investigations on two non-psychotropic, synthetic cannabinoids, HU-211, a neuroprotective agent and HU-308, a specific CB 2 agonist are presented.
Cannabis,Plant cannabinoids,Endogenous cannabinoids,Non-psychotropic,Synthetic cannabinoids,HU-211,Neuroprotective,HU-308,CB2 agonist,Cannabidiol (CBD),Spectroscopy,NMR,Cannabinoids,Geranyl pyrophosphate,Cannabigerol,Cannabigerolic acid,Cannabidiol,Cannabidiolic acid,Cannabichromene,Cannabichromenic acid,Cannabielsoic acid A,Cannabinolic acid,Cannabinol,Cannabicylol,D9-THC,D8-THC,Anandamide,2-arachidonoyl-glycerol (2-AG),HU-211 (DEXANABINOL),NMDA receptor,HU-211 DRUG DEVELOPMENT,Synthesis of HU-308,APPETITE,AIDS,commercial name dronabinol
Hebrew University,Medical Faculty, Department of Medicinal Chemistry and NaturalProducts, Jerusalem 91120, Israel